drugset / Trial / NCT00514865
Placebo-Controlled Study of ONO-2333Ms in Patients With Recurrent Major Depressive Disorder
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate the safety and efficacy of ONO-2333Ms in patients with Recurrent Major Depressive Disorder
Timeline
- Start
- 2007-06-13
- Primary completion
- 2008-04
- Completion
- 2008-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ONO-2333Ms | Small molecule | 1 mg | — |
| Subject | ONO-2333Ms | Small molecule | 2 mg | — |
| Subject | ONO-2333Ms | Small molecule | 5 mg | — |
| Subject | ONO-2333Ms | Small molecule | 10 mg | — |